login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock News
USA
- NASDAQ:ADPT -
US00650F1093
-
Common Stock
17.22
USD
+0.06 (+0.35%)
Last: 10/24/2025, 8:07:59 PM
17.56
USD
+0.34 (+1.97%)
After Hours:
10/24/2025, 8:07:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ADPT Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Zacks Investment Research
- Mentions:
ALNY
IQV
IQVIA Gears Up to Report Q3 Earnings: What's in the Cards?
10 days ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
10 days ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
12 days ago - By: Benzinga
- Mentions:
AGX
EGP
GM
MRK
...
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
25 days ago - By: Benzinga
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts
3 months ago - By: The Motley Fool
Adaptive (ADPT) Q2 Revenue Surges 36%
a month ago - By: Zacks Investment Research
- Mentions:
RARE
IONS
AKRO
IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome
a month ago - By: Zacks Investment Research
- Mentions:
CAH
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
2 months ago - By: Zacks Investment Research
- Mentions:
AQST
ALLO
AKRO
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA
2 months ago - By: Zacks Investment Research
- Mentions:
AGIO
ALLO
AKRO
AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia
2 months ago - By: Zacks Investment Research
- Mentions:
REGN
SNY
AKRO
SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study
2 months ago - By: Zacks Investment Research
- Mentions:
SNY
AKRO
ALGS
Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
2 months ago - By: Zacks Investment Research
Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice
2 months ago - By: Zacks Investment Research
- Mentions:
ANIP
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
2 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
2 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
2 months ago - By: Zacks Investment Research
- Mentions:
PBYI
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
3 months ago - By: Zacks Investment Research
- Mentions:
CAH
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
3 months ago - By: Yahoo Finance
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
3 months ago - By: The Motley Fool
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
3 months ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings
3 months ago - By: Zacks Investment Research
- Mentions:
ACAD
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
3 months ago - By: Zacks Investment Research
- Mentions:
MRNA
Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates
3 months ago - By: Yahoo Finance
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
3 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
3 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
4 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
4 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
4 months ago - By: Yahoo Finance
Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy
5 months ago - By: Adaptive Biotechnologies
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
Please enable JavaScript to continue using this application.